Successor Entity Substituted. 37 SECTION 10.03 Evidence of Consolidation, Etc. to Trustee........................................37
Appears in 3 contracts
Samples: Indenture (Millennium Pharmaceuticals Inc), Indenture (Arch Wireless Inc), Indenture (Neon Communications Inc)
Successor Entity Substituted. 37 39 SECTION 10.03 Evidence of Consolidation, Etc. to Trustee........................................37.............................................39
Appears in 2 contracts
Samples: Indenture (Neon Communications Inc), Indenture (Millennium Pharmaceuticals Inc)
Successor Entity Substituted. 37 28 SECTION 10.03 10.03. Evidence of Consolidation, Etc. to Trustee........................................37........................ 28
Appears in 2 contracts
Samples: Viropharma Inc, Viropharma Inc
Successor Entity Substituted. 37 SECTION 10.03 Evidence of Consolidation, Etc. to Trustee......................................................................37
Appears in 2 contracts
Samples: Satcon Technology Corp, Satcon Technology Corp
Successor Entity Substituted. 37 SECTION 10.03 Section 10.03. Evidence of Consolidation, Etc. to Trustee.................................................................... 37
Appears in 2 contracts
Samples: Viropharma Inc, Viropharma Inc
Successor Entity Substituted. 37 SECTION 10.03 Evidence of Consolidation, Etc. to Trustee........................................37............................................38 ARTICLE XI
Appears in 2 contracts
Samples: Indenture (Genaissance Pharmaceuticals Inc), Section (Genaissance Pharmaceuticals Inc)
Successor Entity Substituted. 37 39 SECTION 10.03 Evidence of Consolidation, Etc. to Trustee........................................37............... 39
Appears in 1 contract
Samples: Arlington Tankers Ltd.
Successor Entity Substituted. 37 SECTION 10.03 Evidence of Consolidation, Etc. to Trustee..........................................................37
Appears in 1 contract
Samples: Akamai Technologies Inc
Successor Entity Substituted. 37 31 SECTION 10.03 Evidence of Consolidation, Etc. to Trustee........................................37................................... 31
Appears in 1 contract
Samples: Indenture (Cmgi Inc)
Successor Entity Substituted. 37 SECTION 10.03 Evidence of Consolidation, Etc. to Trustee............................................................37
Appears in 1 contract
Samples: Akamai Technologies Inc
Successor Entity Substituted. 37 31 SECTION 10.03 Evidence of Consolidation, Etc. to Trustee........................................37................. 31
Appears in 1 contract
Samples: Indenture (Cmgi Inc)
Successor Entity Substituted. 37 SECTION 10.03 29 Section 10.03. Evidence of Consolidation, Etc. to Trustee........................................37................29
Appears in 1 contract
Samples: Orasure Technologies Inc
Successor Entity Substituted. 37 38 SECTION 10.03 Evidence of Consolidation, Etc. to Trustee........................................37......................................... 39
Appears in 1 contract
Samples: Transkaryotic Therapies Inc
Successor Entity Substituted. 37 SECTION 28 Section 10.03 Evidence of Consolidation, Etc. to Trustee........................................37................28
Appears in 1 contract
Samples: Vaxgen Inc
Successor Entity Substituted. 37 SECTION 26 Section 10.03 Evidence of Consolidation, Etc. to Trustee........................................37. .................................... 26
Appears in 1 contract
Samples: Indenture (Telik Inc)
Successor Entity Substituted. 37 SECTION 10.03 29 Section 10.03. Evidence of Consolidation, Etc. to Trustee........................................37.................29
Appears in 1 contract
Samples: Orasure Technologies Inc
Successor Entity Substituted. 37 SECTION 10.03 Evidence of Consolidation, Etc. to Trustee....................................................................................37
Appears in 1 contract
Samples: Transkaryotic Therapies Inc
Successor Entity Substituted. 37 SECTION 10.03 Evidence of Consolidation, Etc. to Trustee.....................................................37
Appears in 1 contract
Successor Entity Substituted. 37 SECTION 10.03 Evidence of Consolidation, Etc. to Trustee........................................37............... 38 ARTICLE XI
Appears in 1 contract
Samples: Critical Therapeutics Inc
Successor Entity Substituted. 37 SECTION 10.03 Evidence of Consolidation, Etc. to Trustee........................................37................................ 38 ARTICLE XI
Appears in 1 contract
Samples: Indenture (Paradigm Genetics Inc)
Successor Entity Substituted. 37 SECTION 40 Section 10.03 Evidence of Consolidation, Etc. to Trustee........................................37............................41
Appears in 1 contract
Samples: Curtiss Wright Corp
Successor Entity Substituted. 37 SECTION 10.03 Evidence of Consolidation, Etc. to Trustee............................................................... 37
Appears in 1 contract
Samples: Rsa Security Inc/De/
Successor Entity Substituted. 37 38 SECTION 10.03 Evidence of Consolidation, Etc. to Trustee........................................37................................ 38 ARTICLE XI
Appears in 1 contract
Samples: Paradigm Genetics Inc
Successor Entity Substituted. 37 SECTION 10.03 Evidence of Consolidation, Etc. to Trustee......................................................... 37
Appears in 1 contract
Samples: Critical Therapeutics Inc
Successor Entity Substituted. 37 39 SECTION 10.03 Evidence of Consolidation, Etc. to Trustee........................................37..................................39
Appears in 1 contract
Samples: Arch Wireless Inc
Successor Entity Substituted. 37 SECTION 49 Section 10.03 Securing of Assets Upon Consolidation, Etc....................................49 Section 10.04 Evidence of Consolidation, Etc. to Trustee........................................37....................................50
Appears in 1 contract
Samples: Consol Energy Inc
Successor Entity Substituted. 37 SECTION 41 Section 10.03 Evidence of Consolidation, Etc. to Trustee........................................37.............................41
Appears in 1 contract
Samples: Indenture (Curtiss Wright Corp)
Successor Entity Substituted. 37 SECTION 29 Section 10.03 Evidence of Consolidation, Etc. to Trustee........................................37.................29
Appears in 1 contract
Samples: Vaxgen Inc
Successor Entity Substituted. 37 SECTION 10.03 Evidence of Consolidation, Etc. to Trustee........................................37................ 38 ARTICLE XI
Appears in 1 contract
Samples: Arlington Tankers Ltd.